Trials / Recruiting
RecruitingNCT07190495
Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy
Preoperative Ginger for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy: A Double-Blind Randomized Controlled Trial
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 102 (estimated)
- Sponsor
- University Tunis El Manar · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate whether preoperative oral administration of ginger (800 mg, given 2 hours before surgery) reduces the incidence and severity of postoperative nausea and vomiting (PONV) within the first 24 hours after laparoscopic cholecystectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ginger | Patients will receive 800 mg of oral ginger 2 hours before laparoscopic cholecystectomy |
| DRUG | Placebo | Patients will receive an oral placebo capsule identical in appearance to ginger, administered 2 hours before laparoscopic cholecystectomy |
Timeline
- Start date
- 2025-07-05
- Primary completion
- 2026-06-01
- Completion
- 2026-12-01
- First posted
- 2025-09-24
- Last updated
- 2025-09-24
Locations
1 site across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT07190495. Inclusion in this directory is not an endorsement.